Alphabet has significant stakes in Anthropic and SpaceX, two businesses that are investing heavily in opportunities related to artificial intelligence (AI). While Anthropic may be the more ...

Alphabet Inc. delivered a strong Q2’26, with Google Cloud backlog surging to $514b and top-line growth of 82%. Despite near-term margin headwinds from capacity constraints and delayed Gemini 3.5 Pro, ...

Alphabet today announced Q2 2026 earnings with $119.8 billion in revenue. These numbers range from April to June. Revenue is up 24% from $96.4 billion in Q2 2025, with operating income at $40.77 ...

Alphabet reported a second-quarter operating margin of 34%, an increase from last year's 32% level. However, the company warned on the earnings call that AI spending could weigh on margins in future ...

If Alphabet’s record-breaking $85 billion stock sale signals investor appetite for AI-related offerings — and it does — we can safely say that investors are voracious. Google’s parent company had ...

Alphabet’s shares fell by 3.9% on 2 June following news that the company was raising $80 billion in fresh capital to fund increased spending on artificial intelligence (AI). The funds are being raised ...

Alphabet said it will raise US$80 billion in equity to fund a rapid expansion of artificial intelligence infrastructure as demand for its services accelerates, signaling a more capital-intensive phase ...

Google LLC parent company Alphabet Inc. is seeking to raise a massive $80 billion in equity capital through a stock sale in an effort to bankroll the ballooning costs of its artificial intelligence ...

Active Gear Review is supported by its audience. If you purchase through links on our site, we may earn an affiliate commission. Bike rack companies are finally starting to catch on to a problem eBike ...

At CES 2026, McKinsey didn't demo a gadget. They demoed a process. And it was more disruptive than anything with a screen. The consulting giant showed a live AI workflow that takes product development ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round. Sources told Bloomberg today that the ...